A decade's worth of impact: Dox loaded liposomes in anticancer activity

A decade's worth of impact: Dox loaded liposomes in anticancer activity

Clinically approved therapeutics associated with cancer are limited to mostly chemotherapy, surgery and radiotherapy in spite of the advancements in the biomedical field. Due to the cardiotoxicity and uncountable side effects brought by the prevailing treatment strategies, demands are growing for ta...

Full description

Bibliographic Details
Main Authors: Puja Ghosh, Himja Tiwari, Jaya Lakkakula, Arpita Roy, Talha Bin Emran, Summya Rashid, Saad Alghamdi, Bodour S. Rajab, Mazen Almehmadi, Mamdouh Allahyani, Abdulelah Aljuaid, Ahad Amer Alsaiari, Rohit Sharma, Ahmad O. Babalghith
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Materials Today Advances
Subjects:
Liposomes
Anticancer
Nanomaterial
Drug delivery
Doxorubicin
Online Access:http://www.sciencedirect.com/science/article/pii/S2590049822001096

Similar Items

Similar Items